methyl (1s,3s)-3-hydroxy-1-methoxycyclobutane-1-carboxylate

Catalog No.: 
ACMFRQ837
CAS No.: 
2231663-95-7
Molecular Formula: 
C7H12O4
Molecular Weight: 
160.17
methyl (1s,3s)-3-hydroxy-1-methoxycyclobutane-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$609.00In stockInquiry
250mg98%$973.00In stockInquiry
500mg98%$1621.00In stockInquiry
1g98%$2429.00In stockInquiry
5g98%$7285.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Namemethyl (1s,3s)-3-hydroxy-1-methoxycyclobutane-1-carboxylate
IUPAC Namemethyl (1s,3s)-3-hydroxy-1-methoxycyclobutane-1-carboxylate
MDL No.MFCD31705172
Molecular FormulaC7H12O4
Molecular Weight160.17
SMILESCOC(=O)[C@]1(OC)C[C@@H](O)C1
InChI KeyGXVXCKZDBNGPFG-IAQIWYKVSA-N
Synonym2231663-95-7 | methyl trans-3-hydroxy-1-methoxycyclobutane-1-carboxylate | 2231665-69-1 | Methyl 3-hydroxy-1-methoxycyclobutane-1-carboxylate | methyl cis-3-hydroxy-1-methoxy-cyclobutanecarboxylate | methylcis-3-hydroxy-1-methoxy-cyclobutanecarboxylate |
CAS No.2231663-95-7
PubChem CID137347052

Synthetic Route by SureRoute

1. ACMFRQ837 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMFRQ837 route product structure diagram
    ACMFRQ8372231663-95-7In Stock
Inquiry

2. ACMFRQ837 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMFRQ837 route product structure diagram
    ACMFRQ8372231663-95-7In Stock
Inquiry

3. ACMFRQ837 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMFRQ837 route product structure diagram
    ACMFRQ8372231663-95-7In Stock
Inquiry

Comments (0)